(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis
Clinical trial NCT02047604 · COMPLETED
Trial details
- NCT number
- NCT02047604
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2017-02-23
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.